-
Small Cap Losers: Himax Technologies(NASDAQ:HIMX), Inovio Pharmaceuticals(NASDAQ:INO), ImmunoGen(NASDAQ:IMGN), Omeros Corporation (NASDAQ:OMER), Enanta Pharmaceuticals(NASDAQ:ENTA)
Himax Technologies, Inc. (NASDAQ:HIMX) a leading supplier and fabless manufacturer of display drivers and other semiconductor products, announced that Google Inc. has decided not to exercise its previously issued purchase option to make an additional investment into Himax’s subsidiary, Himax Display Inc. (“HDI”). Himax has been authorized by Google to make the following statement: “Google…
-
Biotech Unusual Volume – Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), InterMune Inc (NASDAQ:ITMN), Enanta Pharmaceuticals Inc (NASDAQ:ENTA), OHR Pharmaceutical Inc (NASDAQ:OHRP)
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) announced on Friday that the U.S. Food and Drug Administration has accepted the first drug Hetlioz (tasimelteon) 20mg capsules, a melatonin receptor agonist to treat a sleep condition that affects blind individuals. Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) closed at $13.23 in last trading session. Yesterday share price of the company…